Consuming over-processed foods may hasten cognitive decline: study
By
Alicia Lasek
Dec 09, 2022
High consumption of these foods was linked to a 28% faster rate of global cognitive decline and a 25% faster rate of executive function decline, investigators report.
LTC residents have detectable antibodies 6 months after COVID vaccination
By
Alicia Lasek
Apr 12, 2021
All residents tested in University of Pittsburgh Medical Center Senior Communities were found to have antibodies against SARS-CoV-2 after full vaccination. The findings are “cautious good news,”...
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
Simultaneous flu and COVID shots work well in older adults, new study finds
By
Alicia Lasek
Nov 16, 2021
Given together, the vaccines are safe and spur a robust antibody response, a first-of-its-kind trial finds.
Analysis: Medication adherence spotty among U.S. diabetes patients
By
Alicia Lasek
Feb 01, 2023
A sizable percentage of patients with diabetes do not consistently take prescribed medications to lower cholesterol, glucose or blood pressure, investigators say.
What is the best post-acute care destination for an assisted living resident? It’s complicated, new...
By
Alicia Lasek
Jan 31, 2022
Acute care clinicians and discharge planners need more complete information about LTC services and target populations to help ensure that residents land in the most appropriate settings, researchers say.
Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...